Reviewing the occurrence of large genomic rearrangements in patients with inherited cancer predisposing syndromes: importance of a comprehensive molecular diagnosis

Expert Rev Mol Diagn. 2022 Mar;22(3):319-346. doi: 10.1080/14737159.2022.2049247. Epub 2022 Mar 28.

Abstract

Introduction: Hereditary cancer predisposition syndromes are caused by germline pathogenic or likely pathogenic variants in cancer predisposition genes (CPG). The majority of pathogenic variants in CPGs are point mutations, but large gene rearrangements (LGRs) are present in several CPGs. LGRs can be much more difficult to characterize and perhaps they may have been neglected in molecular diagnoses.

Areas covered: We aimed to evaluate the frequencies of germline LGRs in studies conducted in different populations worldwide through a qualitative systematic review based on an online literature research in PubMed. Two reviewers independently extracted data from published studies between 2009 and 2020. In total, 126 studies from 37 countries and 5 continents were included in the analysis. The number of studies in different continents ranged from 3 to 48 and for several countries there was an absolute lack of information. Asia and Europe represented most of the studies, and LGR frequencies varied from 3.04 to 15.06% in different continents. MLPA was one of the methods of choice in most studies (93%).

Expert opinion: The LGR frequencies found in this review reinforce the need for comprehensive molecular testing regardless of the population of origin and should be considered by genetic counseling providers.

Keywords: Cancer predisposition genes; cancer predisposition syndromes; large gene rearrangements; molecular diagnosis; molecular techniques.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Breast Neoplasms* / genetics
  • Female
  • Gene Rearrangement
  • Genes, BRCA2
  • Genetic Predisposition to Disease
  • Genetic Testing / methods
  • Genomics / methods
  • Germ-Line Mutation
  • Humans
  • Neoplasms* / diagnosis
  • Neoplasms* / genetics
  • Syndrome